Bioequivalency

10 registered clinical trials studyying Bioequivalency.

Status	Trial	Sponsor	Phase
Completed	Bioequivalence Study of Iron Sucrose Injection in Healthy Participants NCT06674486	Sichuan Huiyu Pharmaceutical Co., Ltd	Phase 1
Completed	Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects NCT06622148	Sichuan Huiyu Pharmaceutical Co., Ltd	Phase 1
Completed	A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions NCT05665283	Xcovery Holdings, Inc.	Phase 1
Unknown	Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers. NCT01229280	Center for Clinical Pharmacology Research Bdbeq S.A.	Phase 1
Unknown	Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers. NCT01227811	Center for Clinical Pharmacology Research Bdbeq S.A.	Phase 1
Completed	Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting C NCT01039233	Kremers Urban Development Company	Phase 1
Completed	Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions NCT00804401	Perrigo Company	Phase 1
Completed	Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions NCT00803764	Perrigo Company	Phase 1
Completed	Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions NCT00804440	Perrigo Company	Phase 1
Completed	Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions NCT00803946	Perrigo Company	Phase 1